Jonathan P. Mow - 03 Nov 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Chief Executive Officer, Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Nov 2021
Net transactions value
$0
Form type
4
Filing time
03 Nov 2021, 19:30:56 UTC
Previous filing
30 Aug 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise $24,800 +20,000 +14% $1.24* 166,850 03 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Employee Stock Option (right to buy) Options Exercise $24,800 -20,000 -16% $1.24* 108,767 03 Nov 2021 Common Stock 20,000 $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.